Back to insights

Case Study

Biotech Product Acceleration

A fast-scaling biotech company needed to bridge scientific rigor with market agility to introduce three therapies in record time.

Launch Velocity

+18%

Acceleration in getting therapies from lab to market

Regulatory Confidence

95%

Leaders reported confidence navigating new compliance standards

Cross-team Trust

+27%

Increase in collaboration scores across R&D, operations, and marketing

Challenge

Regulatory changes and rapid portfolio growth created silos between labs, operations, and go-to-market teams.

How we responded

  • Designed cross-functional squads with clear decision-rights
  • Introduced leadership simulations mirroring regulatory milestones
  • Implemented reflective coaching for senior scientists moving into people leadership

Key Takeaways

What leaders can apply from this collaboration.

  • Shared rituals bridge lab and commercial mindsets
  • Transparent decision rights prevent bottlenecks
  • Coaching scientists as leaders creates scalable collaboration

Project in Pictures

Scientists collaborating in a lab environment
Workshop session with agile boards and scientists
Team celebrating therapy approval

Cross-functional squads were co-located to speed up decision-making